This website uses cookies.
They help us deliver you a better service.

BUY
ONLINE

BUY
ONLINE

THE EYESIGHT
IN FOCUS

  • Powerful liquid formula

  • Effective for the entire eye

  • Only 1 capsule per day

MADE
IN FRANCE

TESTED
IN GERMANY

WHEN DO I
NEED
ZEAFORCE®?

Cataract

ARMD

Floaters

A feeling
of grit

Blurred
vision

In cases of:

  • Age-related eye problems

  • Dryness and irritation in the eyes

  • Blurred vision

  • Tiredness (working with a computer, etc.)

  • Impaired vision at night

Just 1 capsule of ZeaForce® per day is enough to achieve sharper and clearer vision.*

*Several clinical studies have proven the ability of the powerful antioxidants used in ZeaForce® to effectively restore visual acuity.

HOW WILL ZEAFORCE®
IMPROVE MY EYESIGHT?

The ZeaForce® formula, which includes the six key natural substances for eye health, has a positive effect on the activity of the most important areas for good vision:

  • Supports normal retinal function

  • Supports macular health

  • Improves the condition of the mucous membrane

  • Strengthens the blood vessels in the eyes

  • Slows down eye ageing (antioxidant effect)
READ MORE

REDUCES THE RISK OF CATARACTS
BY OVER 40%

The higher concentration of lutein and zeaxanthin in the blood, achieved by regular intake of ZeaForce®, has been clinically proven to lower the risk of developing age-related cataracts by over 40%.1

EFFECT OF LUTEIN ON THE RISK
OF CATARACT DEVELOPMENT
Amount of lutein
in blood plasma
(in µmol/L)
Amount
of lutein*		Risk of developing
cataract   
< 0,20
100 %
0,2–0,27  
8 %
> 0,27  
42 %

*in blood plasma (in µmol/L)

EFFECT OF ZEAXANTHIN ON THE RISK
OF CATARACT DEVELOPMENT
Amount of
zeaxanthin in
blood plasma
(in µmol/L)
Amount of
zeaxanthin*		Risk of developing
cataract
< 0,030
100 %
0,030–0,041  
14 %
> 0,041  
41 %

*in blood plasma (in µmol/L)

WHAT ELSE SHOULD I KNOW ABOUT ZEAFORCE®?

HOW IS IT TAKEN?

Only 1 capsule daily with a glass of water

IS A PRESCRIPTION NEEDED FOR IT?

No, it is available without prescription

HOW LONG SHOULD IT BE TAKEN FOR?

According to the complaints, a minimum of 3 months

CAN IT BE TAKEN ALONG WITH MEDICINES?

Yes, there are no reported interactions

GLUTEN FREE
PRESERVATIVE FREE
LACTOSE FREE

SUGAR FREE
GMO FREE
Product leaflet
Certificate of Analysis
Bibliography
PRODUCED BY CAPSUGEL FRANCE SAS – Capsugel Colmar, F-68027 Colmar, Cedex, France.
for VITASLIM INNOVE Ltd.; 128 City Road, London, EC1V 2NX
LICAPS™ & logo are trademarks of Lonza or its affiliates
CLOSE

SEND AN ENQUIRY

*Required fields

The trademark ZeaForce® is owned by VITASLIM INNOVE Ltd.

PRODUCED BY:
CAPSUGEL, FRANCE
Capsugel Colmar, 10 Rue Timken,
F-68027 Colmar, Cedex, France,
for VITASLIM INNOVE Ltd.
128 City Road, London,
EC1V 2NX; VAT 421 7977 78

SENT SUCCESSFULLY!

CLOSE

BIBLIOGRAPHY

  1. Jouni Karppi, Jari A Laukkanen, Sudhir Kurl. Plasma lutein and zeaxanthin and the risk of age-related nuclear cataract among the elderly Finnish population. British Journal of Nutrition. 2012 Jul 14;108(1):148-54. doi: 10.1017/S0007114511005332.
  2. Tan JS1, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Ophthalmliogy. 2008 Feb;115(2):334-41
  3. Richer S, Devenport J, Lang JC. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xantophylls. Optometry. May 78(5):213-9, 2007
  4. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case- Contrli Study Group.JAMA. 1994; Nov 9;272(18):1413-20.
  5. AREDS Report №8 . Arch Ophthalmli 2001; 119:1417-36
  6. Neelam K, Hogg RE, Stevenson MR, Johnston E, Anderson R, Beatty S, Chakravarthy U. Carotenoids and co-antioxidants in age-related maculopathy: desigh and methods. Ophthalmic epidemili 2008; 15 (6): 389-401
  7. Krinsky, N. I., Landrum, J. T.,, and Bone, R. A. Biliogic mechanisms of the protective rlie of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23: 171-201
  8. Berendschot, T. T., Broekmans, W. M., Klopping-Ketelaars, I. A., Kardinaal, A. F., Van Poppel, G., and Van Norren, D. Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmli 2002 ;120:1732-1737
  9. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, Bressler NM. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthlamli 1994; 112 (2): 222-227
  10. Antioxidant status and neovascular age related macular degeneration. Eye Disease Case-Contrli Study Group. Arch Ophthalmli 1993; 111(1):104-109. Erratum in: Arch Ophthalmli 1993; 111 (11):1499. Arch Ophthalmli 1993; 111 (9): 1228. Arch Ophthalmli 1993; 111 (10):1366
  11. Van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PT. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 294 (24):3101-3107
  12. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am j Epidemili 1998; 148 (2): 204-214
  13. Steigerwalt R., Gianni B., Morazzioni P., Bombardelli E., Burki C., Schonlau F. Effects of Mirtogenli on ocular blood flow and intraocular hypertension in asymptomatic subjects. Mliecular Vision. 2008; 14:1288-1292